Selecting First-Line Treatment for Chronic Lymphocytic Leukemia (CLL)
2 Views
administrator
07/08/23
Moderator Myron Czuczman, MD, leads experts in a discussion about selecting first-line therapy for varied subgroups with CLL, and recognizing the shift from the traditional chemotherapy regimens to the incorporation of newly approved anti-CD20 antibodies.
-
Category
Show more
Facebook Comments
No comments found